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COL1A2 Mutation in a case of Isolated 
Short Stature.
Harvengt J.1, Boros E. 2, Bulk S. 1, Bours V.1.
Background. The differential diagnosis in a case of short stature in children is wide and difficult. Potential diagnosis
include either endocrine dysfunction or primary skeletal dysplasia. The last two decades have seen serious advances in
our understanding of the genetic underlying growth process with the identification of numerous monogenic causes of
growth disorders. New algorithms have been proposed focusing on the medical evaluation of children with short stature
including genetic workup : single gene-based tests, tests of panel genes and exome sequencing.
Methods. A young boy iniAally aged of 6 months was invesAgated for a severe
growth retardaAon (height – 5,4SD) , dysmorphic features and a coxa vara at the
limit of the normal range.
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At our knowledge, few patients have been described with a COL1A2 mutation and a severe short stature without fractures. In our clinical report, the father present an OI with short stature and DI
without fractures and bone deformities. The child is extremely short, with normal bone phenotype until now.
In the era of exome sequencing, similar cases will probably be collected. Series of patients could be described to better characterized the correlation with genotype and phenotype and delineated an
alternative phenotype of OI.
A long term evaluation of these patients could be interesting with a particular attention for the bone phenotype, the growth velocity and the dentinogenesis.
A multidisciplinary follow up specific for OI is even recommended for these patients.
Definition of Osteogenesis Imperfecta (OI).
« A heterogeneous group of diseases characterized by susceptibility to bone fractures with variable
severity and presumed or proven defects in collagen type I biosynthesis” ». (Van Dijk et al., 2010)
Classification of OI.
In 1979, the original Sillence classification of OI in four types (OI type I to IV), was based on clinical
findings with a radiological subclassification. This description assumed that OI is an heterogene
syndrome. In 2004 and 2007, an expanded classification included a total of 8 types. (Van Dijk et al.,
2010)
The clinical features can be resumed according to the types of OI (the main 4 types). It appears that
no description correlate with our clinical observation. An alternative phenotype of OI will probably
emerge in the next years to better describe such patients.
Regulation of childhood growth is a combination of molecular mechanisms. Genetic defect can affect every step
leading to growth plate.
Dysregulation of COL1A1/A2 lead to an alteration of the organic matrix skeletal tissue. COL1A1/A2 encode for the
collagen type I which constitutes 85% of the skeletal tissue and forms a framework for mineral deposition, rendering
bone the tensile properties needed to withstand torsion and bending powers.
Collagenopathies due to mutation in COL2, COLl9, COL10, and COL11 are known to be associated with several
dysplasia phenotypes. Alterations of the synthesis of non collagen matrix proteins led to dysfunction of the growth
plate chondrocytes. (Andrade et al., 2017 ; Jee et al., 2017 ; Lindhal K. et al., 2015)
COL1A1/A2 is the principal component of the bone matrice. It is supposed that an alteration in the bone structure
causes an alteration in molecular interactions for the growth plate chondrocytes. Alike, more genes implicated in the
extracellular matrix formation will probably be discovered as related to idiopathic short stature.
OI and isolated short stature
Cases of OI with severe short stature and without any fractures are rarely described in the
literature.
In a case reported by Tulun et al., an exome sequencing performed to explore a short
stature in a child identified a COL1A2 class 4 variant in the mother. The reported mother
size was 126 cm without medical story of bone fragility.
In cases of familial idiopathic osteoporosis, some genetic studies reveal pedigrees with
COL1A1/A2 mutations with description of fractures in adulthood and some degree of short
stature in the adult patients but mainly linked to the bone fragility. Among the children
described in these cohorts, all of them have a normal height or a relative short stature (-1 or
-2 SD). ( Al Kaissi et al., 2017)
Dentinogenesis imperfecta (DI)
Classically, it is reported that patients with DI are more likely to have fractures at birth and
have a globally higher fractures frequencies. Patients with DI presented with a more severe
short stature and more severe skeletal deformities. (Andersson K et al., PlosOne 2017)
Ø Here we expand the spectrum of the phenotype with patient presenting DI as the only
clinical symptom associated with a significative short stature.
Results.
General biology : normal
Hormonal biology : normal
Array CGH : 46,XY
Short Stature panel : pathogenic variant in COL1A2 (class 5) , 
c.1171G>A p(Gly391Ser), inherited from the father.
SHOX : negative
FGFR3 : negative
RASopathy panel : negative
GNAS : in process 
TYPE Severity Fractures Bone
deformity
Stature DI Sclerae Hearing loss
Classic OI Mild Few to 100 Uncommon Normal Rare Blue About 50%
Lethal OI Perinatal lethal Multiples Severe Severely short + Dark blue /
Progressively
deforming OI
Severe Thin ribs, platyspondyly, 
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Growth failure : Different steps of molecular mechanisms
152,2 cm 140,7 cm
-Both parents presented an isolated short
stature.
-The father is described with fragile teeth.
-Prenatal US : shortening of long bones.
